scispace - formally typeset
A

Andreas von Knethen

Researcher at Kaiserslautern University of Technology

Publications -  16
Citations -  1322

Andreas von Knethen is an academic researcher from Kaiserslautern University of Technology. The author has contributed to research in topics: Apoptosis & Nitric oxide. The author has an hindex of 15, co-authored 16 publications receiving 1292 citations. Previous affiliations of Andreas von Knethen include University of Erlangen-Nuremberg.

Papers
More filters
Journal ArticleDOI

Nitric oxide and its role in apoptosis

TL;DR: No shares with other toxic molecules such as tumor necrosis factor-alpha the unique ability to initiate and to block apoptosis, depending on multiple variables that are being elucidated, and will determine the role of NO in apoptotic cell death.
Journal ArticleDOI

NF-κB and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages

TL;DR: The importance of AP-1 for Cox-2 expression and cell protection by low-level NO was substantiated by using the extracellular signal-regulated kinase inhibitor PD98059, blocking NO-elicited Cox- 2 expression, but leaving the cytokine signal unaltered.
Journal ArticleDOI

Activation of the cell death program by nitric oxide involves inhibition of the proteasome.

TL;DR: It is shown that, similar to nitric oxide, treatment of macrophages with specific proteasome inhibitors, including clastolactacystin-β-lactone, induces p53 accumulation and apoptosis, suggesting thatNitric oxide may affect the activity of the proteasomes.
Journal ArticleDOI

Activation of Peroxisome Proliferator-Activated Receptor γ by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst

TL;DR: It is concluded that NO participates in controlling the pro- vs anti-inflammatory phenotype of macrophages by modulating PPARγ.
Journal ArticleDOI

Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases.

TL;DR: It is suggested that NO or a metabolite acts directly at the level of the apoptosome and inhibits the sequential activation of caspases-9, -3 and -8, which are required for both stress- and receptor-induced death in cells that use the mitochondrial subroute of cell demise.